| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Trump's comments on health-care negotiations with Democrats can put ETFs like XLV, IHF, and XHS back on investors' rada...
The Trump administration is investigating Medicaid spending in California and other Democrat-led states over potential misuse i...
Experts raise alarms about Health Secretary Robert F. Kennedy Jr's decision to layoff tens of thousands of federal workers,...
ETFs that provide exposure to sectors that have historically been considered defensive during downturns are now in the limelight.
Robert F. Kennedy Jr.'s appointment as Secretary of Health and Human Services has sparked concerns over funding for the NIH.
A federal judge halted NIH's plan to cap indirect grant costs at 15%, citing potential harm to research. A hearing is set f...
Goldman Sachs predicts a gradual recovery for Life Sciences Tools in 2025, with bioprocessing gaining traction and improved inv...
The year of milestones, 2024, has seen an unperturbed rise in the bull market, we recap 2024's landmark junctures in the U....
U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private i...